Clinical and laboratory data Demographic, clinical, and laboratory data obtained at the time of biopsy and during follow -up were derived from patients' medical records. The variables included sex, age, urinary protein excretion, systolic and diastolic blood pressures (SBP and DBP, respectively), degree of hematuria, serum creatinine, albumin, and uric acid levels, hemoglobin (Hb) concentration, serum lipid levels, use of medications, history of tonsillectomy, and concomitant diseases. Proteinuria was estimated by measuring the protein concentration in a 24 -hour urine sample or by the protein -to -creatinine ratio of the first morning spot urine. Arterial hypertension was defined as an SBP of 140 mmHg and higher or DBP of 90 mmHg and higher or the use of antihypertensive therapy; anemia as Hb levels lower than 13.5 g/dl in men and lower than 12 g/dl in women; hypoalbuminemia as serum albumin levels lower than 3 mg/dl; hyperuricemia as serum uric acid levels exceeding 7.5 mg/dl in men and 5.7 mg/dl in women; hypertriglyceridemia as serum triglyceride (TG) levels exceeding 150 mg/dl; and hypercholesterolemia as serum total cholesterol (TC) levels exceeding 200 mg/dl. Poorly controlled arterial hypertension was considered as an SBP of 140 mmHg and higher or DBP of 90 mmHg and higher. A history of tonsillectomy as well as the records of frequent or chronic infections of the upper respiratory tract were considered as upper respiratory tract disorders.
GFR was estimated using the abbreviated Modification of Diet in Renal Disease equation. The mean arterial pressure (MAP) was defined as DBP plus one -third of SBP. Time -weighted averages were calculated for MAP and proteinuria from the area under the curve (AUC) of all measurements during follow-up. Time -average MAP (TA -MAP) was defined as the ratio of the AUC of the MAP to the duration of follow -up. Time--average proteinuria (TA -P) was determined using the same method as that for TA -MAP.
The rate of renal function decline was expressed as the velocity of eGFR decline, which was obtained by fitting a straight line through the values of eGFR measured at every visit during follow--up using linear regression and the principle of the least squares. These values were plotted and examined for each patient.
The follow -up started on the day of kidney biopsy. The endpoint was defined as an increase of serum creatinine levels by 50%.
Histopathological data Histopathological data were obtained from the recorded biopsy results, which were available for 42 of the 52 patients. All samples had been examined in the course of routine diagnostic work up.
The biopsy results were examined for 7 histopathological features, of which 4 were derived from the Oxford classification, 3 were estimated according to the following criteria: mesangial hypercellularity score (M; M0 ≤0.5; M1 >0.5),
In this retrospective study of adult patients with biopsy -proven IgAN, we sought to identify clinical markers allowing to discriminate between individuals with a progressive and nonprogressive course. We also tested the applicability of the Oxford classification for assessing prognosis in the population from our institution and evaluated additional, non -Oxford kidney biopsy findings.
PATIENTS AND METHODS Patients
We enrolled consecutive patients with biopsy -proven IgAN admitted to the Department of Nephrology and Transplantation Medicine of the Wroclaw Medical University, Poland, between May 2008 and February 2014. The inclusion criteria were as follows: age at diagnosis over 18 years and estimated glomerular filtration rate (eGFR) higher than 15 ml/min/1.73 m 2 . Patients with postbiopsy follow -up period shorter than 6 months or with insufficient medical records were excluded. The final study population consisted of 52 subjects. Since there were patients with incomplete data for single clinical parameters, statistical analyses for those variables were performed after exclusion of those subjects. Therefore, the exact number of the analyzed patients is given for every variable.
A P value of less than 0.05 was considered statistically significant. All statistical analyses were performed using the Statistica 10 software (StatSoft Inc., Tulsa, Oklahoma, United States).
RESULTS Baseline clinical parameters
The baseline clinical characteristics of the study cohort are shown in TABLE 1. Throughout the follow--up period, the study population demonstrated the mean TA -P level of 1.2 ±1.0 g/d (n = 47) and mean TA -MAP values of 95 ±7 mmHg (n = 49).
Survival analysis
The median follow -up period of the entire cohort of 52 patients was 14 months (8-42 months). Eight subjects (15.4%) reached the endpoint. The clinical factors predictive of an increase in serum creatinine levels by 50% in univariate Cox proportional regression models are presented in TABLE 2. These included TA -P, baseline eGFR of less than 60 ml/min/1.73 m 2 , and a history of tonsillectomy. Arterial hypertension demonstrated the prognostic value when poorly controlled; however, in other cases, it did not affect the renal outcome. The baseline proteinuria level was significant in this analysis. In the multivariate Cox model (χ 2 = 13.6, P = 0.003), TA -P exceeding 2.0 g/d, a history of tonsillectomy, and eGFR of less than 60 ml/min/1.73 m 2 proved to be independent prognostic factors. Kaplan-Meier event -free survival curves for these 3 features are shown in FIGURE 1.
endocapillary hypercellularity (E; E0 when absent; E1 when present), and segmental sclerosis (S; S0 or S1 analogically to E). The assessment of the fourth Oxford parameter, tubular atrophy/interstitial fibrosis ratio (T), was modified to the semiquantitative categorization of both tubular atrophy (TA) and interstitial fibrosis (IF) separately according to the extent of the affected interstitium (TA: TA0 for 0%-25%; TA1 for >25%; IF: IF0 for 0%-25%; IF1 for >25%-50%; IF2 for >50%). Three additional, non -Oxford features were incorporated, including the global sclerosis index (GSI), expressed as the percentage of glomeruli showing global sclerosis; crescent index (C; C0 for 0%; C1 for >0%-25%; C2 for >25%), and the presence of interstitial inflammation (I; I0 when absent; I1 when present).
Statistical analysis Normally distributed continuous variables were expressed as means with standard deviations, and their intergroup differences were tested using the t test. The remaining continuous variables had a skewed distribution, and were expressed as medians with lower and upper quartiles; the intergroup differences were tested using the Mann-Whitney test. Categorical variables were expressed as numbers with percentages, and their intergroup differences were tested using the χ 2 test with Yates' correction for continuity. A bivariate correlation analysis was performed using the Pearson's correlation coefficient.
The associations between the analyzed variables and event -free survival were established using Cox proportional hazards models (both univariate and multivariate), and Kaplan-Meier curves were constructed for factors determined by the multivariate model. Differences in event -free survival rates were tested using the log -rank test.
To establish clinical and histopathological determinants of the velocity of eGFR decline, a univariate followed by multivariate linear regression Abbreviations: C -crescents, CI -confidence interval, GSI -global sclerosis, HR -hazard ratio, IF -interstitial fibrosis, NS -nonsignificant, TAtubular atrophy, TA-P -time-average proteinuria, others -see TABLE 1 than Renal impairment Similarly to clinical parameters, histopathological findings were examined for the relationship with the velocity of eGFR decline (TABLE 3) . GSI and I correlated with a more rapid filtration loss in the univariate regression analysis. Of these 2 factors, GSI proved to be an independent determinant of the velocity of eGFR decline in the multivariate model (r 2 = 0.3, P <0.001). The positive correlation between GSI and the annual rate of renal function decline is shown in FIGURE 2B. DISCUSSION In this study, we tested a set of clinicopathological parameters to detect predictors of the IgAN progression, and thus to identify patients who are likely to benefit from close monitoring and an earlier or more aggressive therapy. Significant clinical factors revealed by the multivariate Cox regression analysis include: baseline impairment of renal function, a history of tonsillectomy, and TA-P exceeding 2 g/d, the latter representing the average level of proteinuria throughout the follow-up period.
The strength of our study lies in collecting several clinical and laboratory data at every followup visit. TA-P was independently related to renal outcome, while the baseline level of proteinuria had no prognostic value. Additionally, we demonstrated a positive correlation of TA-P with the rate of renal function decline. These findings confirm that achieving clinical remission by reducing More patients with TA -P exceeding 2.0 g/d met the endpoint compared with those with lower TA-P values (42.9% vs. 7.5%; P = 0.047; n = 47). IgAN progression was observed significantly more often in patients with the baseline eGFR of less Renal impairment at diagnosis is a well-documented predictor for progression of IgAN. 10, 11 In the present study, baseline eGFR of less than 60 ml/min/1.73 m 2 was the strongest marker for progression, associated with an almost 8-fold increase in the risk of reaching the endpoint.
There is an ongoing debate over the curative value of tonsillectomy in IgAN. Some reports from Japan have suggested that tonsillectomy has beneficial effects on clinical remission (disappearance of urine abnormalities) and delayed renal deterioration, especially when combined with steroid treatment. However, these studies failed to demonstrate that tonsillectomy alone could affect the development of ESRD. [12] [13] [14] Two European research groups addressed this issue and found that tonsillectomy did not prevent progression of IgAN to advanced renal disease. 15, 16 Finally, a recent metaanalysis found that tonsillectomy alone did not improve clinical outcomes compared with those obtained with general treatment.
17 Unlike in many Japanese centers, tonsillectomy is not regarded as a routine adjuvant treatment for IgAN in our center and was performed for indications voiced solely by otolaryngologists. Therefore, the surgery was not accompanied by corticosteroid treatment, which was suggested to be the crucial determinant of therapy effectiveness. The possible explanation for the association between a history of tonsillectomy and an unfavorable renal outcome in the present study is the more severe initial symptomatology of renal disease in patients with IgAN scheduled for this procedure.
In the current study, the presence of microscopic hematuria accelerated the rate of eGFR decline. Previously reported findings are inconsistent. The association of hematuria with IgAN progression was observed in 2 studies performed in patients at an early stage of renal disease. 18, 19 It was hypothesized that a rising number of urinary erythrocytes might indicate a high degree of glomerular inflammation in the initial course of renal impairment.
18,19 However, our cohort included patients in a more advanced stage of chronic urinary protein excretion over time below a certain threshold value is crucial for securing a favorable renal outcome, regardless of the baseline urinary protein excretion. 8 The cut-off point of TA-P was set at 1 g/d or even 0.5 g/d in a few large long-term studies.
4,9 Our analysis was probably underpowered to detect the significance of such small values owing to the modest sample size. outcome. Our results are supported by a recent meta-analysis of 16 retrospective cohort studies, which concluded that crescents (along with M, S, and T lesions) strongly correlate with progression to kidney failure. Furthermore, the authors suggested that E lesions should be excluded from the Oxford classification because they did not prove to be significant predictors of disease progression. In addition, no interaction with immunosuppressive therapy was confirmed. This was the main reason why those features were included in the score in the first place. The role of E lesions is expected to be clarified by the ongoing European Validation Study of the Oxford Classification of IgAN (VALIGA).
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Our study has several limitations. First, it was a retrospective, observational study in a single center. Secondly, the investigated cohort was relatively small, which affected the statistical power.
In conclusion, our study provides an insight into both clinical and histopathological markers that should be useful in risk stratification, outcome prediction, and planning of therapeutic interventions in patients with IgAN. We demonstrated that the extent of proteinuria during follow-up and impaired renal function at diagnosis remain the most significant prognostic factors for the progression of IgAN. As for the Oxford classification, only T proved to be of prognostic significance in our study. As for additional, non-Oxford histopathological features that predict the risk for progression of IgAN, GSI and the presence of crescents should be mentioned.
kidney disease compared with the above studies. In addition, other reports did not show the prognostic value of hematuria. 10,11 Therefore, although our results suggest that microscopic hematuria negatively affects the course of IgAN, it needs to be confirmed in further research.
Even though hyperuricemia was reported as an independent marker for IgAN progression in some studies, we found a relationship between this feature and a higher velocity of eGFR decline only in the univariate model. 4, 5 Our results do not support the concept that other recently suggested parameters including anemia, hypoalbuminemia, dyslipidemia, and the presence of urinary casts could be used to predict renal outcome in IgAN.
Apart from evaluating the clinical risk factors for IgAN progression, our study was also designed to test the applicability of the Oxford classification in the cohort from our institution. The Oxford classification identifies 4 histopathological features as predictors for renal outcome in IgAN, including mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), and tubular atrophy/interstitial fibrosis ratio (T). In the original paper, the Cox regression analysis showed a significant association for M and T and the endpoint of an increase in serum creatinine levels by 50%. 6, 20 In the present study, we used the same endpoint and found that, of the 2 above variables, only T (interpreted in a modified manner, as described in the Methods section) proved to have prognostic relevance. We also demonstrated that patients with I displayed an increased velocity of eGFR decline in the multivariate model. Our findings are in line with the results of other researchers that interstitial lesions are better prognostic indicators for renal outcome than glomerular lesions. It is believed that tubulointerstitial changes are the most reliable marker of chronic and irreversible renal damage in glomerulopathies.
18,21
We reported additional, non-Oxford histopathological features that predict the risk for progression of IgAN, including the GSI and the presence of crescents. For the GSI, a positive correlation with the velocity of eGFR decline was demonstrated (r = 0.511). A similarly strong correlation (r = 0.53) was also reported in other studies. 22 GSI is simple to assess and shows excellent intraobserver reproducibility. 20 It directly reflects the loss of functioning nephrons and is associated with established chronic kidney injury. Patients with high GSI are likely to have reached the so called point of no return, beyond which the self-perpetuating renal injury inevitably leads to the development of ESRD. 23 The issue of crescents was not addressed in the Oxford study owing to the low prevalence of these lesions. In our validation population, more crescents were observed since patients with rapidly progressive glomerulonephritis who are most likely to display extracapillary proliferation were not excluded. Therefore, we could demonstrate that crescent formation was an independent negative predictor of poor renal
